UAB Hematology Review 2021
Therapeutic Options for R/R MM: Single Agent vs. Doublets vs. Triplets, Summary for Triple Refractory Disease
By
UAB Hematology Review 2021
FEATURING
Kelly Godby
By
UAB Hematology Review 2021
FEATURING
Kelly Godby
Login to view comments.
Click here to Login